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218 A snapshot audit of the dietary fruit and vegetable consumption
in adults with cystic ﬁbrosis (CF): How many portions are
consumed daily?
R.S. Chinuck. Nottingham University Hospitals, City Campus, Nottingham, United
Kingdom
Background: There is no literature documenting the fruit and vegetable intake of
patients with CF. Recommendations for consuming 5 ortions of fruit and vegetable
a day may not be met due to the emphasis placed on macronutrient intake by the
CF team.
Aims: To ascertain the number of portions of fruit and vegetables consumed daily;
To examine the attitude, understanding and perception of patients with CF to eating
fruit and vegetables.
Methodology: Ten patients were approached by the CF Dietitian randomly in
outpatient’s clinic over 6 months to self-complete a validated food frequency and a
general questionnaire examining knowledge on the factors contributing to the fruit
and vegetable intake.
Results: Patient Demographics: Six females and four males; age 19−53 years;
BMI 17.7−27.7; all were pancreatic insufﬁcient. Daily Fruit and Vegetable Con-
sumption Reported by Patients: 1 (13%) patient did not know; 1 (13%) question-
naire was incomplete; 1 (13%) patient consumed 1−2 portions; 2 (26%) patients
consumed 2−3 portions; 2 (26%) patients consumed 4−5 portions; 3 (38%) patients
consumed >5 portions. Summary of Attitude, Understanding and Perception of
Patients with CF to Eating Fruit and Vegetables: 80% reported that they would
like to eat more; 20% worried about being overweight; 10% worried about being
underweight; 17% didn’t feel they ate a balanced or healthy diet; 20% enjoyed their
diet; 10% thought too much emphasis was placed on the caloric intake.
Conclusions: Daily fruit and vegetables intake appears variable. There are mixed
views on perceptions, understanding and attitudes to eating fruit and vegetables.
219 Energy intake from PEG feeds and long-term anthropometric
changes in children with CF
D. Hopkins1, S. Langton Hewer2. 1Nutrition and Dietetics, Bristol Children’s
Hospital, Bristol, United Kingdom; 2Respiratory Medicine, Bristol Children’s
Hospital, Bristol, United Kingdom
Background: A minority of children with cystic ﬁbrosis (CF) fail to achieve
satisfactory weight gain in spite of intensive dietary counselling and oral energy
supplementation. We reviewed 15 children who had failed to achieve adequate
weight gain, requiring percutaneous endoscopic gastrostomy (PEG) placement for
supplementary feeding. We attempted to identify the proportion of the estimated
average requirement (EAR) for energy required from PEG feeds to achieve satis-
factory weight and height gain.
Method: Retrospective data on weight and height were obtained in the year before
and in the 2 years following PEG placement. Standard deviation scores (SDS) were
used to assess changes in weight and height. Information on energy and protein
intake from overnight PEG feeds was obtained to see whether there was a correlation
between intake and anthropometric changes. Paired student’s t tests were used to
assess changes.
Results: In the year to PEG placement this population had a signiﬁcant fall in
weight and height SDS (p = 0.012 and 0.016 respectively). In the year following PEG
placement signiﬁcant improvements in weight and height SDS occured (p = 0.005
and 0.017). Children having greater than 40% EAR from PEG feeds tended to
have better improvement in weight SDS. By 2 years following PEG placement
the improvements in weight and height were no longer signiﬁcant in the whole
population. However, with the removal of 2 outliers, who were found to have poor-
compliance, improvement in weight SD scores was maintained.
Conclusion: A recommended minimum of 40% of estimated average energy
requirement should be provided from PEG feeds in order to achieve satisfactory
improvements in weight and height SD scores in children with CF.
220 Obesity in childhood cystic ﬁbrosis
M. Stack1, M. Mahony1, C. Boyle2. 1Paediatrics, Limerick Regional Hospital,
Limerick, Ireland; 2Nutrition and Dietetics, Limerick Regional Hospital, Limerick,
Ireland
Obesity has become a very important public health problem in childhood. As the
prevalence of obesity increases so does the prevalence of the comorbidities. More
children are being identiﬁed as obese in the cystic ﬁbrosis population.
Obesity refers to children with BMI> 95 percentile for age and sex and overweight
refers to children with BMI between the 85th-95th percentile. Type 2 diabetes
mellitus and steatohepatitis, that used to be considered “adult diseases” are now
regularly seen in overweight children.
We performed a chart review of 68 children, 0−16 years of age, attending Limerick
Regional Hospital cystic ﬁbrosis unit. BMI was calculated on all patients and plotted
over time. Characterisics of cases identiﬁed included genotype, age and BMI at
diagnosis. Evidence of adverse effects of obesity were examined, HbA1c, lipid
proﬁles, liver function tests and albumin, coagulation. Liver ultrasound appearances
were recorded.
Of the 68 cases reviewed 4 (5.9%) were obese (>98th). 5 (7.4%) children fell into
the overweight group. (91−98th percentile).
In the obese children the genotype was DF508 in 3/4. 50% were premorbidly
overweight at time of diagnosis. Abnormal liver function with evidence of steato-
hepatitis was identiﬁed in one obese case. 2 cases had abnormal liver ultrasound but
no other concern. Blood pressure, fat soluble vitamins and HbA1c measurements
were normal in all cases of obesity.
We are using Z score analysis to further validate results.
Although the numbers of obese and overweight are small, the future implications
are large. Overweight and obese children are evidence of the progress in nurtitional
interventions combined with genetic and environmental inﬂuences. these children
merit special attention at the clinic.
221* Do overweight and obesity improve clinical outcome in the
French cystic ﬁbrosis population?
A. Munck1, G. Bellis2, S. Ravilly3, F. Huet4. 1CF Center Robert Debre´,
Paris, France; 2INED, Paris, France; 3Vaincre la mucoviscidose, Paris, France;
4University hospital, Dijon, France
Aim: We assessed the respiratory function and the CF co-morbid conditions
according to the patients’ nutritional status.
Methods: data were collected from the French Observatory 2004 (n = 4533)
(INED): Weight (W), height (H), FEV1, FVC, genotype, pancreatic enzymes
consumption, pseudomonas aeruginosa (PA), cirrhosis, diabetes and mortality rate.
(SAS 9.1) (exclusion criteria: transplantation). We used international age-adjusted
standards for BMI z-score for children (C) and BMI for adults (A) (Cole TJ BMJ
2000) to deﬁne underW (UW), normal W (NW), overW (OW) and obesity (OB).
Results: 2647 patients in C and 1498 patients in A cohort (36%). Nutritional status
subgroups prevalence (%) is: 6.1, 87.1, 5.6 and 1.2 in C and 37.3, 57.7, 4.3 and
0.7 in A for respectively UW, NW, OW and OB. Mean age in A is increasing with
BMI (p< 0.0001). Frequency of F508 /F508 (p< 0.02), use of pancreatic enzymes
(p< 0.001) in C and A are lower in OW/OB and these patients have the best
FEV1 and FVC whatever their gender and age, with less PA colonization in A
(p< 0.01). We found a positive correlation between pulmonary function and BMI.
CF co-morbid conditions demonstrated a lower prevalence of diabetes (12/257) and
cirrhosis (5/257) in OW/OB; none are on a transplant waiting list versus 1.7% in
UW/NW and none died versus 1% in UW/NW.
Conclusion: OW/OB prevalence in CF is respectively 5.2 and 1% whereas the
French ObEpi 2003 collected 30 and 11%. Our results suggest a beneﬁcial effect of
high BMI on FEV1, FVC, prevalence of PA, cirrhosis and diabetes. Potential risks
of chronically high BMI have not been studied in this population yet, but justify
further investigations in this longer life expectancy cohort.
